Is phosphodiesterase type 5 inhibitor use associated with condom breakage?
We tested the hypothesis that phosphodiesterase type 5 inhibitor (PDE5i) use would be associated with increased likelihood of condom breakage using an event-specific analysis. A convenience sample of 440 men completed an internet-based questionnaire that assessed variables pertaining to the last t...
Main Authors: | Crosby, R. (Author), Yarber, W. L. (Author), Sanders, S. A. (Author), Graham, C. A. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2009.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage?
by: Sanders, Stephanie A., et al.
Published: (2009) -
Two heads are better than one: the association between condom decision-making and condom use errors and problems
by: Crosby, R., et al.
Published: (2008) -
Assessment of condom use in men and women
by: Graham, Cynthia A., et al.
Published: (2005) -
Does it fit okay? Problems with condom use as a function of self-reported poor fit
by: Crosby, R. A., et al.
Published: (2010) -
Incomplete use of condoms: the importance of sexual arousal
by: Graham, Cynthia A., et al.
Published: (2011)